Stay updated on SAGE-217 in Severe Postpartum Depression Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 in Severe Postpartum Depression Clinical Trial page.

Latest updates to the SAGE-217 in Severe Postpartum Depression Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing Revision: v3.4.1, indicating a minor maintenance update that does not affect study data or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedUI updates add Show glossary and Hide glossary options and update metadata labels to Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check40 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no visible changes to study details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedExpanded the study location list to include Arkansas, California, District of Columbia, Florida, Georgia, Illinois, Kentucky, Louisiana, Missouri, Nevada, New York, North Carolina, Rhode Island, Texas, and Utah. Removed the HHS Vulnerability Disclosure link from the page.SummaryDifference1%

- Check90 days agoChange DetectedThe Publications section now states that publications are voluntarily entered and may be auto-filled from PubMed, and the Revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to SAGE-217 in Severe Postpartum Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 in Severe Postpartum Depression Clinical Trial page.